|
4-(2-amino-1H-imidazol-5-yl)-N-tridecan-7-ylbutanamide;hydrochloride |
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry
|
|
N-Tridecyl-2-amino-1H-imidazole-4-butyramide |
Depiction based on curated SMILES
N
NH
2
HN
O
N
H
H
3
C
|
Acinetobacter Streptococcus |
BfmRS Biofilm |
Preclinical (in vitro) Preclinical (in vivo) |
Thompson RJ, et al. 2012. Biochemistry Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N-tridecylbutanamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
H
2
N
N
H
N
O
CH
3
|
Acinetobacter Pseudomonas Staphylococcus |
Biofilm Biofilm Regulation |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vivo) |
Ballard TE, et al. 2008. Chemistry
Liu C, et al. 2023. mBio |
|
4-(2-amino-1H-imidazol-5-yl)-N,N-dihexylbutanamide;hydrochloride |
Depiction based on curated SMILES
H
3
C
ClH
H
2
N
N
H
N
O
CH
3
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
5-(2-amino-1H-imidazol-5-yl)-N-hexylpentanamide;hydrochloride |
Depiction based on curated SMILES
ClH
H
2
N
N
H
N
CH
3
O
HN
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
N-(3-(2-Aminopyrimidin-5-yl)prop-2-yn-1-yl)octanamide |
Depiction based on curated SMILES
H
2
N
N
N
CH
3
NH
O
|
Pseudomonas Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Lindsey EA, et al. 2012. Org Biomol Chem
|
|
N-[3-(2-aminopyrimidin-5-yl)propyl]decanamide |
Depiction based on curated SMILES
NH
N
H
2
N
N
CH
3
O
|
Staphylococcus |
Biofilm |
Preclinical (in vitro) |
Lindsey EA, et al. 2012. Org Biomol Chem |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |